Flt-3 Ligand Inhibits Growth of Human Ovarian Tumors Engrafted in Severe Combined Immunodeficient Mice

By Silver D.F.   Hempling R.E.   Piver M.S.   Repasky E.A.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 377-382

Elsevier

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect

By Silver D.F.   Piver M.S.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 280-284

Elsevier

Access to resources Recommend Favorite

Characterization of Human Ovarian Carcinomas in a SCID Mouse Model

By Xu Y.   Silver D.F.   Yang N.-P.   Oflazoglu E.   Hempling R.E.   Piver M.S.   Repasky E.A.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 161-170

Elsevier

Access to resources Recommend Favorite

Generation of human tumor-specific CTLs in HLA-A2.1–transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors

By Gritzapis Angelos   Sotiriadou Nectaria   Papamichail Michael   Baxevanis Constantin  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 1027-1040

Springer Publishing Company

Access to resources Recommend Favorite

Human T- and B-cell functions in SCID-hu mice

By Roncarolo M.G.   Carballido J.M.   Rouleau M.   Namikawa R.   de Vries J.E.  

Seminars in Immunology, Vol. 8, Iss. 4, 1996-04 ,pp. : 207-213

Academic Press

Access to resources Recommend Favorite